Race and ethnicity, area-level social determinants of health linked to delayed or discontinued cancer treatment
Risk for SARS-CoV-2 Breakthrough Infection Increased for Cancer Patients
Risk for severe outcomes of COVID-19 higher for patients with hematologic versus solid cancer
Mortality Disparities by Education Widened in the U.S. in 2020
Considerable increases in disparities seen for heart disease, cancer, cerebrovascular disease, unintentional injury mortality from 2019 to 2020
Fourth Vaccination Ups Immunity to Omicron Variants in Cancer Patients
Humoral response seen in patients receiving B cell-targeted therapy for hematologic malignancy, patients with solid malignancies
Uninsured Rate Did Not Change in 2020 for 18- to 64-Year-Olds
Prevalence of certain unhealthy behaviors decreased, while self-rated health improved, regardless of cancer history
COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose
Worldwide Drop in Cancer Screening Seen Early in Pandemic
Significant drops in cancer screening observed for several types of cancer
Disruption to Oncology Clinical Trials Seen Early in Pandemic
Numbers of new patient accruals and newly activated trials decreased early on, followed by progressive recovery
ASCO: Disparities Seen in Telehealth Use for Cancer Care During Pandemic
Disparities according to race, geographic location, socioeconomic status seen for telehealth use among patients initiating cancer treatment